Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Study With SUTENT® In The First Line Treatment Of Renal Cell Cancer

NCT00460798 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00460798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Study With SUTENT® In The First Line Treatment Of Renal Cell Cancer
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
September 30, 2009
Enrollment
356 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma